Allergy, Asthma & Clinical Immunology (Mar 2022)

Growth in diagnosis and treatment of primary immunodeficiency within the global Jeffrey Modell Centers Network

  • Jessica Quinn,
  • Vicki Modell,
  • Jordan S. Orange,
  • Fred Modell

DOI
https://doi.org/10.1186/s13223-022-00662-6
Journal volume & issue
Vol. 18, no. 1
pp. 1 – 19

Abstract

Read online

Key messages 1. The JMCN has steadily and substantially grown for more than 2 decades and continues to significantly influence the global Immunology community. 2. In addition to compiling an extensive global patient database, the expanding JMCN acts as a unique and critical resource, increasing awareness of PIs, educating physicians and patients, and facilitating diagnosis via expertise and genetic sequencing, as well as treatment. 3. The JMCN provides a platform to optimize research advances, earliest diagnosis, enhanced treatments, and implement standard-of-care and best practices through maximized connectivity, resulting in a better quality of life and improved outcomes for patients with PI.

Keywords